141 related articles for article (PubMed ID: 1669802)
1. Prophylaxis against Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus.
CDR (Lond Engl Wkly); 1991 Apr; 1(15):65. PubMed ID: 1669802
[No Abstract] [Full Text] [Related]
2. Pneumocystis carinii pneumonia prophylaxis during pregnancy.
Connelly RT; Lourwood DL
Pharmacotherapy; 1994; 14(4):424-9. PubMed ID: 7937279
[TBL] [Abstract][Full Text] [Related]
3. Trimethoprim-sulfamethoxazole prophylaxis of Pneumocystis carinii pneumonia in infants.
Mueller BU; Pizzo PA
Pediatr Infect Dis J; 1992 Dec; 11(12):1072-3. PubMed ID: 1461709
[No Abstract] [Full Text] [Related]
4. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
[TBL] [Abstract][Full Text] [Related]
5. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Le Moal G; Breux JP; Roblot F
N Engl J Med; 2001 May; 344(21):1639-41. PubMed ID: 11374363
[No Abstract] [Full Text] [Related]
6. Protect yourself from Pneumocystis carinii.
AIDS Alert; 1999 Jun; 14(6):suppl 1-2. PubMed ID: 11366414
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected infants and children.
Goodwin SD
Pharmacotherapy; 1993; 13(6):640-6. PubMed ID: 8302691
[TBL] [Abstract][Full Text] [Related]
8. Discontinuing prophylaxis against Pneumocystis carinii pneumonia.
Bender MA; Sax PE
N Engl J Med; 2001 May; 344(21):1639; author reply 1640-1. PubMed ID: 11374364
[No Abstract] [Full Text] [Related]
9. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.
Gaut P; Daar ES
Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888
[No Abstract] [Full Text] [Related]
10. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
11. Intravenous pentamidine as an alternate for Pneumocystis carinii pneumonia prophylaxis in children with HIV infection.
Gupta M; Stephenson K; Gauar S; Frenkel L
Pediatr Pulmonol Suppl; 1997; 16():199-200. PubMed ID: 9443273
[No Abstract] [Full Text] [Related]
12. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
[TBL] [Abstract][Full Text] [Related]
13. Impact of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in a cohort of 1000 patients with AIDS.
Monforte AD; Mainini F; Bini T; Moscatelli GC; Antinori S; Formenti T; Testa L; Mena M; Moroni M
J Chemother; 1995 Nov; 7 Suppl 4():184-6. PubMed ID: 8904150
[No Abstract] [Full Text] [Related]
14. Does the choice of Pneumocystis carinii prophylaxis influence the prevalence of Enterocytozoon bieneusi microsporidiosis in AIDS patients?
Albrecht H; Sobottka I; Stellbrink HJ; Greten H
AIDS; 1995 Mar; 9(3):302-3. PubMed ID: 7755923
[No Abstract] [Full Text] [Related]
15. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa.
;
Afr Health Sci; 2001 Aug; 1(1):30-1. PubMed ID: 12833907
[No Abstract] [Full Text] [Related]
16. A randomized trial of daily and thrice-weekly trimethoprim-sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).
El-Sadr WM; Luskin-Hawk R; Yurik TM; Walker J; Abrams D; John SL; Sherer R; Crane L; Labriola A; Caras S; Pulling C; Hafner R
Clin Infect Dis; 1999 Oct; 29(4):775-83. PubMed ID: 10589887
[TBL] [Abstract][Full Text] [Related]
17. Prevention of Pneumocystis carinii pneumonia relapse in AIDS patients. The efficacy and tolerability of low-dose sulfamethoxazole-trimethoprim.
Nielsen TL; Jensen BN; Nelsing S; Pedersen C; Mathiesen LR; Skinhøj P; Nielsen JO
Dan Med Bull; 1993 Sep; 40(4):503-5. PubMed ID: 8222772
[TBL] [Abstract][Full Text] [Related]
18. High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children.
Nachman SA; Mueller BU; Mirochnick M; Pizzo PA
Pediatr Infect Dis J; 1994 Nov; 13(11):1004-6. PubMed ID: 7845719
[No Abstract] [Full Text] [Related]
19. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
[TBL] [Abstract][Full Text] [Related]
20. Low-dose intermittent trimethoprim-sulfamethoxazole for prevention of Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection.
Wormser GP; Horowitz HW; Duncanson FP; Forseter G; Javaly K; Alampur SK; Gilroy SA; Lenox T; Rappaport A; Nadelman RB
Arch Intern Med; 1991 Apr; 151(4):688-92. PubMed ID: 1901482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
